Working... Menu

An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01384162
Recruitment Status : Terminated (Issues with development and supply of infusion system for delivery of IMP. Lack of favorable benefit risk ratio in sNN0029-003 study (review of interim data).)
First Posted : June 28, 2011
Last Update Posted : January 27, 2016
ICON Clinical Research
Information provided by (Responsible Party):
Newron Sweden AB

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2015
  Actual Study Completion Date : October 2015